A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)

Clinical trial NCT00749502 · COMPLETED

Trial details

NCT number: NCT00749502
Sponsor: Tesaro, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors Chronic Lymphocytic Leukemia T-cell-prolymphocytic Leukemia

Start date: 2008-09-01
Primary completion: 2011-09-01
Enrollment: 113

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.